RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
Philadelphia, PA · Pittsburgh, PA · +29 more sites
Colorectal Cancer clinical trials in Pittsburgh, PA
25 recruiting colorectal cancer studies with a site in Pittsburgh, PA.
RecruitingPhase 1 / Phase 2NCT06710756
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Sponsor: Perspective Therapeutics
Pittsburgh, PA · +15 more sites
RecruitingPhase 3NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Sponsor: Merck Sharp & Dohme LLC
Easton, PA · Pittsburgh, PA · +46 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
Pittsburgh, PA · +15 more sites
RecruitingPhase 1NCT04429542
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Sponsor: Bicara Therapeutics
Pittsburgh, PA · +14 more sites
RecruitingPhase 3NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Lebanon, PA · Philadelphia, PA · +109 more sites
RecruitingPhase 2NCT05673148
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Sponsor: Alliance for Clinical Trials in Oncology
Chadds Ford, PA · Danville, PA · Hershey, PA · +185 more sites
RecruitingNot applicableNCT07059884
Distance-Based Exercise to Preserve Function and Prevent Disability
Sponsor: Alliance for Clinical Trials in Oncology
Butler, PA · Indiana, PA · New Castle, PA · +20 more sites
RecruitingPhase 1NCT05877599
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Sponsor: AstraZeneca
Pittsburgh, PA · +19 more sites
RecruitingPhase 1 / Phase 2NCT05482893
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Sponsor: Phanes Therapeutics
Pittsburgh, PA · +10 more sites
RecruitingPhase 1NCT06218914
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Sponsor: AstraZeneca
Philadelphia, PA · Pittsburgh, PA · +16 more sites
RecruitingPhase 3NCT05863195
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Sponsor: ECOG-ACRIN Cancer Research Group
Allentown, PA · Erie, PA · Jefferson Hills, PA · +59 more sites
RecruitingPhase 1NCT07020117
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Sponsor: Aktis Oncology, Inc.
Pittsburgh, PA · +13 more sites
RecruitingPhase 1NCT07812805
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
Sponsor: SK Life Science, Inc.
Pittsburgh, PA · +1 more sites
RecruitingPhase 1 / Phase 2NCT04851119
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Sponsor: Children's Oncology Group
Philadelphia, PA · Pittsburgh, PA · +19 more sites
RecruitingPhase 1NCT06586515
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Sponsor: Eli Lilly and Company
Pittsburgh, PA · +24 more sites
RecruitingPhase 1 / Phase 2NCT05691491
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Sponsor: National Cancer Institute (NCI)
Pittsburgh, PA · +22 more sites
RecruitingPhase 1NCT06657144
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Sponsor: Coherus Oncology, Inc.
Pittsburgh, PA · +19 more sites
RecruitingPhase 1NCT05283330
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Sponsor: Orano Med Theranostics, SAS
Pittsburgh, PA · +7 more sites
RecruitingPhase 3NCT06950385
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Sponsor: Rapamycin Holdings Inc.
Danville, PA · Pittsburgh, PA · +16 more sites
RecruitingPhase 2NCT07223424
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Sponsor: Diwakar Davar
Pittsburgh, PA
RecruitingPhase not listedNCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Sponsor: UMC Utrecht
Pittsburgh, PA · +2 more sites
RecruitingPhase 1 / Phase 2NCT03539822
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
Sponsor: Anwaar Saeed
Pittsburgh, PA · +1 more sites
RecruitingPhase 3NCT02000089
The Cancer of the Pancreas Screening-5 CAPS5)Study
Sponsor: Johns Hopkins University
Philadelphia, PA · Pittsburgh, PA · +7 more sites
RecruitingNot applicableNCT06731998
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Pittsburgh, PA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.